课题基金 / 基金详情

Molecular Mechanisms of Peripheral Prion Pathogenesis

Molecular Mechanisms of Peripheral Prion Pathogenesis
外周朊病毒发病机制的分子机制
批准号:
8834317
负责人:
Sarah Jo Kane
金额:
$3.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2017-09-29

项目摘要

项目成果

Sarah Jo Kane的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):朊病毒疾病影响包括人类在内的许多物种,但目前缺乏对这些总是致命的神经退行性疾病的治疗。拟议研究的思想包括了解朊病毒在到达大脑之前如何传播和繁殖,在那里它们造成神经变性和随后的死亡。虽然免疫系统通常有助于清除身体的感染,但朊病毒却反直觉地利用免疫系统中称为补体的特定部分传播到复制部位。具体来说,如果你对老鼠进行基因操作,使其缺乏某些补体蛋白,这些动物要么完全抵抗疾病,要么表现出延迟的疾病发作。免疫系统由两个主要分支组成:第一道防线,称为先天免疫,和一个较慢但更特异的分支,称为适应性免疫。补体主要通过识别病原体常见但在宿主细胞上不存在的模式,在身体对抗感染因子的第一道防线中发挥作用。考虑到朊病毒使用补体来传播疾病,其中的目标之一涉及通过表面等离子体共振来表征天然来源的朊病毒和补体蛋白之间的相互作用,表面等离子体共振是用于研究分子相互作用的广泛使用的技术。鉴定直接结合具有最大强度的蛋白质的补体蛋白质可以提供用于预防疾病进展的治疗靶点。因子H抑制宿主组织的补体识别,因此在预防自身免疫中起作用。其他研究表明,H因子既能结合正常折叠的朊病毒蛋白,也能结合错误折叠的朊病毒蛋白。这些发现提出了一个问题,即H因子是否通过阻止补体识别在限制朊病毒传播中发挥作用。第二个目标将测试的假设,即因子H预防朊病毒疾病结合朊病毒和抑制补体识别。如果H因子确实在朊病毒疾病中起这种作用,那么缺乏H因子的小鼠将比H因子充足的小鼠更快地死于朊病毒疾病。如果是这样,那么也许过表达或用因子H治疗可以限制疾病进展。最终,拟议的项目平行NINDS使命,通过了解神经系统疾病的原因和进展的共同目标,最终目标是提供潜在的治疗目标。
英文摘要
DESCRIPTION (provided by applicant): Prion diseases affect numerous species including humans, but a cure for these invariably fatal, neurodegenerative diseases is currently lacking. The ideology of the proposed research involves understanding how prions spread and propagate before they reach the brain where they inflict neurodegeneration and subsequent death. Although the immune system normally aids in clearing the body of infections, prions counter-intuitively utilize a specific part of the immune system termed Complement to spread to sites of replication. Specifically, if you genetically manipulate mice to lack certain Complement proteins, the animals either resist disease entirely or exhibit a delayed disease onset. The immune system consists of two main branches: the first line of defense, termed innate immunity, and a slower yet more specific branch termed adaptive immunity. Complement plays a role in the body's first line of defense against an infectious agent mainly through recognizing patterns common to pathogens yet absent on host cells. Considering prions use Complement to spread disease, one of the aims within involves characterizing the interaction between naturally derived prions and Complement proteins through surface plasmon resonance, a broadly used technology used for studying molecular interactions. Identifying the Complement proteins which directly bind proteins with the greatest strength could provide therapeutic targets for preventing disease progression. Factor H inhibits Complement recognition of host tissues and thus plays a role in preventing autoimmunity. Others have shown Factor H binds both normally folded as well as misfolded prion protein. These findings raise the question of whether Factor H plays a role in limiting the spread of prions through preventing Complement recognition. The second aim described within will test the hypothesis that Factor H prevents prion disease by binding prions and inhibiting Complement recognition. If Factor H indeed plays this role in prion disease, then mice deficient in Factor H will succumb to prion disease at a faster rate than Factor H sufficient mice. If so, then perhaps overexpression or treatment with Factor H could serve to limit disease progression. Ultimately, the proposed projects parallel the NINDS mission through the shared goal of understanding causes and progression of neurological diseases with the ultimate goal to provide potential therapeutic targets for a cure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving influenza vaccines through wastewater-based macro-scale strain surveillance
  • 批准号:
    10385514
  • 项目类别:
  • 资助金额:
    $25.66万
  • 财政年份:
    2022
  • 负责人:
    Sarah Jo Kane
  • 依托单位:
Molecular Mechanisms of Peripheral Prion Pathogenesis
  • 批准号:
    9123685
  • 项目类别:
  • 资助金额:
    $3.43万
  • 财政年份:
    2014
  • 负责人:
    Sarah Jo Kane
  • 依托单位:
Molecular Mechanisms of Peripheral Prion Pathogenesis
  • 批准号:
    8929026
  • 项目类别:
  • 资助金额:
    $3.39万
  • 财政年份:
    2014
  • 负责人:
    Sarah Jo Kane
  • 依托单位:
海外基金